Benign Hysterectomy · Route Selection

Step-by-step decision

Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.

🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).

Full pathway

1. [Decision] Uterine size/descent + adnexa/adhesions/prior surgery
   Uterine size and mobility/descent? Adnexal disease/adhesions/prior surgery? Malignancy suspected? (For benign disease, prefer the least invasive feasible route; if malignancy is suspected, avoid power morcellators (occult uterine sarcoma risk).)
   • Uterus not large, some descent/good vaginal access, no severe adhesions → Vaginal (preferred)
   • Vaginal not feasible (larger uterus, need to address adnexa, adhesions, exploration) → Laparoscopic/robotic
   • Huge uterus/severe adhesions/malignancy/need for extensive exploration → Open (only when necessary)
2. [End] Vaginal (preferred)
   Vaginal hysterectomy — preferred when feasible: no abdominal incision, fewest complications, fastest recovery; suits a not-too-large uterus with descent, adequate vaginal width, and no need to address the adnexa.
3. [End] Laparoscopic/robotic
   Laparoscopic (or robotic) hysterectomy — better than open when vaginal is not feasible: suits a larger uterus, need to address adnexa/endometriosis/adhesions or upper abdominal exploration; faster recovery and fewer complications than open.
4. [End] Open (only when necessary)
   Open (abdominal) hysterectomy — only when other routes are unsafe/infeasible: huge uterus, dense adhesions, suspected or confirmed malignancy, need for extensive staging exploration; for suspected malignancy remove en bloc, avoid morcellation.

Source guidelines & references

• Benign hysterectomy route selection (ACOG Committee Opinion 701; AAGL; vaginal route preferred)

This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.

Other pathways